RoustitMGuilhaumouRMolimardMDriciM-DLaporteSMontastrucJ-L. Chloroquine and hydroxychloroquine in the management of COVID-19: much kerfuffle but little evidence. Therapie. 2020;75:363-370. doi:10.1016/j.therap.2020.05.010
2.
NaranjoCABustoUSellersEM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245. doi:10.1038/clpt.1981.154
3.
Serious cardiac AEs with hydroxychloroquine during COVID-19 pandemic. React Wkly. 2020;1806(1):9.
4.
HooksMBartBVardenyOWestanmoAAdabagS. Effects of hydroxychloroquine treatment on QT interval. Heart Rhythm. 2020;17:1930-1935. doi:10.1016/j.hrthm.2020.06.029
5.
DoynoCSobierajDMBakerWL. Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose. Clin Toxicol (Phila). Published online September 22, 2020. doi:10.1080/15563650.2020.1817479
6.
AlanSÜnalBYildirimA. Premature ventricular contractions associated with isotretinoin use. An Bras Dermatol. 2016;91:820-821. doi:10.1590/abd1806-4841.20165138
